Skip to main content

Table 1 Physical characteristics of patients with prostate cancer before and after androgen deprivation therapy (n = 16)

From: Androgen deprivation therapy improves the in vitro capacity of high-density lipoprotein (HDL) to receive cholesterol and other lipids in patients with prostate carcinoma

 

Basal

Post-treatment

P-value

Weight (kg)

71.0 ± 13.1

74.5 ± 13.9

0.0001

BMI (kg/m2)

26.7 ± 4.9

27.0 ± 3.4

0.660

Testosterone (ng/dL)

527 ± 226

< 12

0.001

PSA (ng/mL)

361 ± 508

13 ± 21

0.001

  1. BMI Body mass index, PSA Prostate-specific antigens